Log in to search using one of your social media accounts:

 

‘Unmet need’ for aftercare in women with cervical cancer
It is essential that the “very real consequences” of diagnosis and treatment for cervical cancer are recognised, specialist nurses have said in response to a new report. (Source: Nursing Times)
Source: Nursing Times - September 20, 2017 Category: Nursing Source Type: news

Rwanda: Spanish Oncologists to Train Local Health Professionals in Cervical Cancer Prevention
[New Times] More than 88 health professionals from 45 institutions in the country have started training in cervical cancer prevention. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 20, 2017 Category: African Health Source Type: news

Malawi: First Lady Gives Malawi's Experience in Cancer Fight
[Malawi News Agency] New York -The First Lady Madame Dr. Gertrude Mutharika says the establishment of facilities like the National Cervical Cancer Control Programme has helped in scaling up screening and treatment of pre cancerous lesions in Malawi. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 19, 2017 Category: African Health Source Type: news

Malawi: Cancer Awareness Initiative Reaches Out to 5,000 Women
[Nyasa Times] Think Pink Malawi, an initiative designed to reach out to rural women with breast and cervical cancer awareness has so far reached out to at least 5,000 women since 2014. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 19, 2017 Category: African Health Source Type: news

Screening for cervical abnormalities in women offered HPV vaccination
(PLOS) Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Pap smears in a female population including a proportion offered HPV vaccination, according to a new study published in PLOS Medicine by Karen Canfell of Cancer Council New South Wales, Australia, researchers at the Victorian Cytology Service, Melbourne, Australia, and colleagues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 19, 2017 Category: Cancer & Oncology Source Type: news

Bloating or bleeding: Symptoms of the FIVE gynaecological cancers YOU should know
WOMB, ovarian, cervical, vaginal and vulval cancers are the types of gynaecological cancers, but few women know the symptoms of the diseases. (Source: Daily Express - Health)
Source: Daily Express - Health - September 15, 2017 Category: Consumer Health News Source Type: news

Cervical Cancer Screening Recommendations - Opportunity for Public Comment
The USPSTF seeks comments on a draft recommendation statement anddraft evidence review on screening for cervical cancer. The draft recommendation statement and draft evidence review are available for review and public comment from September 12, 2017 to October 9, 2017. (Source: HSR Information Central)
Source: HSR Information Central - September 13, 2017 Category: International Medicine & Public Health Source Type: news

Why age matters when it comes to cervical cancer screening
What to know about testing options that can detect early warning signs of cancer and help prevent it (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 13, 2017 Category: Consumer Health News Source Type: news

USPSTF Backs Cervical Cancer Screening With Cytology or hrHPV
Recommendations for screening with cytology alone every three years or hrHPV testing every five years (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 13, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Nursing, Oncology, Pathology, Institutional, Source Type: news

Age matters when it comes to screening for cervical cancer
Middle-aged women can choose which test to undergo for cervical cancer screening, according to a draft recommendation from an influential group backed by the U.S. government. (Source: CBC | Health)
Source: CBC | Health - September 13, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert Panel
Title: HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert PanelCategory: Health NewsCreated: 9/12/2017 12:00:00 AMLast Editorial Review: 9/13/2017 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - September 13, 2017 Category: OBGYN Source Type: news

HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert Panel
New advisory says women can get the screen once every 5 years, in lieu of Pap tests every 3 years (Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - September 13, 2017 Category: Cancer & Oncology Source Type: news

USPSTF Draft Recommendation Eliminates Cervical Cytology-HPV Cotesting for Women Over 30 (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Women aged 30 –65 should undergo cervical cancer screening with either cervical cytology alone every 3 years or high-risk human papillomavirus … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 12, 2017 Category: Primary Care Source Type: news

Middle-age women can choose Pap smear or HPV test for cancer screening
(Reuters Health) - Middle-aged women can choose which test to undergo for cervical cancer screening, according to a draft recommendation from an influential group backed by the U.S. government. (Source: Reuters: Health)
Source: Reuters: Health - September 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Cervical cancer screenings are about to get much easier
The US Preventative Services Task Force is now recommending that women should be able to choose between getting an HPV test every five years or a Pap smear every three. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2017 Category: Consumer Health News Source Type: news

Screen For Cervical Cancer Over 30 With HPV Test
New advisory says women can get the screen once every 5 years, in lieu of Pap tests every 3 years (Source: WebMD Health)
Source: WebMD Health - September 12, 2017 Category: Consumer Health News Source Type: news

HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert Panel
New advisory says women can get the screen once every 5 years, in lieu of Pap tests every 3 years (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 12, 2017 Category: Cancer & Oncology Tags: Gynecology, Infections, Oncology, Preventive Medicine, News, Source Type: news

HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert Panel
New advisory says women can get the screen once every 5 years, in lieu of Pap tests every 3 years Source: HealthDay Related MedlinePlus Pages: Cervical Cancer Screening, HPV, Women's Health Checkup (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 12, 2017 Category: Consumer Health News Source Type: news

USPSTF Has New Draft Guidance for Cervical Cancer Screening USPSTF Has New Draft Guidance for Cervical Cancer Screening
The only major change is that the USPSTF no longer recommends testing in women 30 years and older.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Age matters when it comes to screening for cervical cancer
Getting checked for cervical cancer isn't one-size-fits-all, as draft guidelines offer women 30 and older a choice of testing (Source: ABC News: Health)
Source: ABC News: Health - September 12, 2017 Category: Consumer Health News Tags: Health Source Type: news

HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert Panel
TUESDAY, Sept. 12, 2017 -- An influential U.S. panel of health experts is boosting support for the HPV test as a routine part of cervical cancer screening. The independent U.S. Preventive Services Task Force (USPSTF) -- which issues closely heeded... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 12, 2017 Category: General Medicine Source Type: news

Chemoradiotherapy Remains Standard of Care in Cervical Cancer Chemoradiotherapy Remains Standard of Care in Cervical Cancer
Chemoradiotherapy remains the standard of care for cervical cancer patients with locally advanced disease, concludes an Indian trial that compared it to neoadjuvant chemotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study confirms chemoradiation is best treatment for locally advanced cervical cancer
(European Society for Medical Oncology) A 14-year randomized trial in more than 600 patients has concluded that chemoradiation should remain the standard treatment for patients with locally advanced cervical cancer. The findings are reported today at the ESMO 2017 Congress in Madrid. The trial demonstrated no improved disease-free survival with neoadjuvant chemotherapy followed by surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2017 Category: Cancer & Oncology Source Type: news

Improving cervical cancer screening rates for transgender men
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papillomavirus (HPV) testing, could improve the screening rate among transgender men. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

Study shows vaccine confirmed to reduce and eradicate cervical cancer
The benefits of Gardasil are wildly debated across the United States by concerned parents, and the University of Alabama at Birmingham is paying attention. UAB's Comprehensive Cancer Center, along with a medical coalition of Alabama health groups, have made inroads into displaying Gardasil's effectiveness. According to a new study from the coalition, recent results confirm that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers. D r. Warner Huh, professor and director in the gynecologic… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 7, 2017 Category: Health Management Authors: Tyler Patchen Source Type: news

Human papillomavirus 16 infections may pose variable cancer risk
(Cell Press) Human papillomavirus 16 accounts for about half of all cervical cancers, but researchers reporting Sept. 7 in the journal Cell have found that not all infections are equal. An analysis of the HPV16 genome from 5,570 human cell and tissue samples revealed that the virus actually consists of thousands of unique genomes, such that infected women living in the same region often have different HPV16 sequences and variable risks to cancer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 7, 2017 Category: Infectious Diseases Source Type: news

NAS, NAM Members Receive Lasker Awards
The Albert and Mary Lasker Foundation announced today that NAS member Michael N. Hall, professor, Biozentrum, University of Basel, Switzerland, is the recipient of the 2017 Albert Lasker Basic Medical Research Award for"discoveries concerning the nutrient-activated TOR proteins and their central role in the metabolic control of cell growth." Dual NAS/NAM member Douglas Lowy, acting director of the National Cancer Institute, has been awarded the 2017 Lasker~DeBakey Clinical Medical Research Award, along with John T. Schiller of the NCI, for"technological advances that enabled development of HPV vaccines for p...
Source: News from the National Academies - September 6, 2017 Category: Science Source Type: news

3 Scientists and Planned Parenthood Win Lasker Prizes for Medical Research
(NEW YORK) — Two scientists who paved the way for widely used vaccines and another who discovered key players in cell growth have been awarded prestigious medical research awards. The Albert and Mary Lasker Foundation also announced Wednesday that it was giving its public service award to Planned Parenthood. Each award includes a $250,000 honorarium. The foundation’s clinical research award is shared by Dr. Douglas Lowy and John Schiller of the U.S. National Cancer Institute. In the early 1990s they began work that would eventually lead to vaccines against human papillomavirus, or HPV, which causes cervical can...
Source: TIME.com: Top Science and Health Stories - September 6, 2017 Category: Consumer Health News Authors: Malcolm Ritter / AP Tags: Uncategorized awards medical research onetime Planned Parenthood Science Source Type: news

HPV researchers, Planned Parenthood win prestigious Lasker medical awards
The Lasker Awards, among the most prestigious in medicine, will go to two National Cancer Institute researchers whose work led to the development of vaccines that prevent cervical cancer, and to Planned Parenthood for providing “essential health services and reproductive care” to millions of women, the Albert and Mary Lasker Foundation said Wednesday. In announcing the awards, […]Related:The health dangers from Hurricane Harvey’s floods and Houston’s chemical plantsFDA clears first gene-altering therapy — ‘a living drug’ — for childhood leukemiaThe hurricane ...
Source: Washington Post: To Your Health - September 6, 2017 Category: Consumer Health News Source Type: news

New study finds improved vaccine that protects against nine types of HPV
(H. Lee Moffitt Cancer Center& Research Institute) Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer. And thanks to an international effort to improve the vaccine, the medical community is one step closer to preventing more HPV-associated diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 6, 2017 Category: Cancer & Oncology Source Type: news

Zimbabwe: Making Quality Cervical Cancer Prevention Accessible
[The Herald] The Zimbabwe National Cervical Cancer Control and Prevention Strategy (ZCCCPS) (2017-2020) was launched by Minister of Health and Child Care, Dr David Parirenyatwa, at the Gweru Provincial Hospital recently. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 5, 2017 Category: African Health Source Type: news

New study finds improved vaccine that protects against nine types of HPV
Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly reduced the number of those who develop and die from cervical cancer. And thanks to an international effort to improve the vaccine, the medical community is one step closer to preventing more HPV-associated diseases. (Source: World Pharma News)
Source: World Pharma News - September 5, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Vaccine to prevent most cervical cancers shows long-term effectiveness
This study of 14,215 women in 18 countries extends and solidifies the initial phase 3 efficacy and safety trial of the nine-valent human papilloma virus vaccine, Gardasil 9, that was published in February 2015 in The New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 5, 2017 Category: Cancer & Oncology Source Type: news

50% Of Men Don't Know Where The Vagina Is, According To UK Study
September is Gynecological Cancer Awareness month, which aims to bring more attention and understanding of five cancers: ovarian, uterine, cervical, vaginal and vulvar. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 3, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Health Tip: Getting the HPV Vaccine
-- Human papillomavirus (HPV) is a sexually transmitted disease that has been linked to cancer of the cervix and a host of other cancers. The HPV vaccine is designed to prevent infection by the HPV-16 and HPV-18 strains of the virus, which are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 30, 2017 Category: General Medicine Source Type: news

Ethiopia: Breast Cancer Replaces Cervical Cancer As Leading Illness Among Ethiopian Women
[Ethiopian Herald] Breast cancer is becoming the most prevalent illness among women in Ethiopia replacing cervical cancer, says specialist in the field. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 26, 2017 Category: African Health Source Type: news

Ethiopia: Breast Cancer Replaces Cervical Cancer As Leading Illness
[Ethiopian Herald] Breast cancer is becoming the most prevalent illness among women in Ethiopia replacing cervical cancer, says specialist in the field. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 26, 2017 Category: African Health Source Type: news

Improving Access to Cervical Cancer Screening and Treatment Improving Access to Cervical Cancer Screening and Treatment
Integrating cervical cancer screening and treatment into family planning services is a promising strategy in sub-Saharan countries with few cancer resources.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 25, 2017 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

HPV vaccine: What is the virus linked to anal cancer and how is it spread?
HPV has been linked to anal cancer, cervical cancer and mouth cancer, but few people know what the virus is or how people can be infected by it. (Source: Daily Express - Health)
Source: Daily Express - Health - August 25, 2017 Category: Consumer Health News Source Type: news

Study paves the way for cancer treatments that might prevent relapses after radiotherapy
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Brazilian researchers suggest that the combination of drugs that block a protein called PAF-R may increase radiotherapy's killing of tumor cells by one third. The experiments that proved the involvement of PAF-R in tumor repopulation were performed with human oral cancer cells and murine cervical cancer cells, in which radiotherapy is usually preferred. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 25, 2017 Category: Cancer & Oncology Source Type: news

South Africa: New Cancer Policies to Improve Prevention and Treatment for Women
[SAnews.gov.za] Health Minister Dr Aaron Motsoaledi will on Friday launch cervical and breast cancer policies aimed at addressing the high mortality caused by these two types of cancers. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 23, 2017 Category: African Health Source Type: news

Iovance commences LN-145 dosing in Phase II trial for cervical cancer
US-based biotechnology firm Iovance Biotherapeutics has commenced patient dosing in its Phase II C-145-04 clinical trial of LN-145 to treat recurrent, metastatic or persistent cervical carcinoma. (Source: Drug Development Technology)
Source: Drug Development Technology - August 16, 2017 Category: Pharmaceuticals Source Type: news

Cytology versus HPV testing for cervical cancer screening in the general population: a DTA Review from the Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group, (CGNOC)
Cochrane Reviews are systematic reviews of research in health care and policy. They are internationally recognized as a high-quality source of evidence for decision-making. They collate and summarize all the best available research evidence on the effects of healthcare interventions or the accuracy of diagnostic tests into a systematic review.Diagnostic Test Accuracy Reviews (DTA) provide essential information regarding the accuracy of the available diagnostic tools for key decision makers, including patients, clinicians, guideline developers and researchers.  The purpose of a Cochrane DTA review is very like the purp...
Source: Cochrane News and Events - August 14, 2017 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

7 medtech stories we missed this week: August 11, 2017
[Image from unsplash.com]From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions for the Calix-C cervical inter body cages. The clearance allows for two larger footprints to be added for use with allograft. The Calix-C Cervical Interbody Spacer is designed for spinal fusion procedures at level one in patients who are skeletally m...
Source: Mass Device - August 11, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Clinical Trials Food & Drug Administration (FDA) Oncology Regulatory/Compliance Spinal Surgical Apifix Cardiac Science Hip Innovation Life Spine Inc. MedTech Pentax Medical Varian Medical Systems Xtant M Source Type: news

Adding Bevacizumab to Chemo Boosts Survival in Advanced Cervical Cancer Adding Bevacizumab to Chemo Boosts Survival in Advanced Cervical Cancer
The overall survival (OS) benefit seen with bevacizumab in advanced cervical cancer persists with extended follow-up, new research shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 7, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Physicians evaluate new device to test for cervical cancer
(University of California - Riverside) When a woman has an abnormal pap smear she usually undergoes colposcopy. Typically a metal instrument is used to obtain a small sampling of cells inside the cervix--an oftentimes painful procedure for the patient. A clinical faculty member in the UC Riverside School of Medicine and colleagues have tested an alternative device called fabric-based endocervical curettage. This less painful device had significantly fewer 'inadequate' specimens--meaning, patients didn't need to return for repeat biopsies. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 2, 2017 Category: International Medicine & Public Health Source Type: news

Cryotherapy or cervical cancer screening in HIV-infected women?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2017 Category: Drugs & Pharmacology Source Type: news

2 methods to de-identify large patient datasets greatly reduced risk of re-identification
(American Association for Cancer Research) Two de-identification methods, k-anonymization and adding a 'fuzzy factor,' significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 28, 2017 Category: International Medicine & Public Health Source Type: news

For Women of Color, Access to Vital Health Services Is Threatened
Across a broad range of issues, the policy priorities of the Trump administration and conservatives in Congress are likely to have a devastating impact on many Americans. One group at particular risk from current efforts to undo the Affordable Care Act (ACA), gut Medicaid and slash domestic programs are women of color, their families and communities.   Women of color have long experienced stark health disparities in areas like cervical and breast cancer, unintended pregnancy, and pregnancy-related complications. The root causes stem from a long history of racism and discrimination, including lack of access to high-qua...
Source: The Guttmacher Institute - July 27, 2017 Category: International Medicine & Public Health Authors: Guttmacher Source Type: news

Scottish mother, 24, dies from cervical cancer
Louise Smith, from Hamilton, Scotland, tragically lost her two-year battle with cervical cancer last week. The mother-of-two was diagnosed with stage 4 cervical cancer in October 2015. (Source: the Mail online | Health)
Source: the Mail online | Health - July 27, 2017 Category: Consumer Health News Source Type: news